06:20 AM EDT, 08/05/2024 (MT Newswires) -- Eli Lilly and Company's ( LLY ) weight loss drug Zepbound and diabetes treatment Mounjaro are now available in the US in all doses, according to the US Food and Drug Administration's updated drug shortage database.

Mounjaro have been in shortage since as early as 2022, while Zepbound was added to the list earlier this year, according to a Reuters report.

Price: 770.00, Change: -34.46, Percent Change: -4.28